Insider · CIK 0002120886
Tim Jasper Knotnerus
ceoofficerdirector
Files at AGMB (AgomAb Therapeutics NV). First filing Oct 7, 2026, latest Oct 7, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$94k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AGMB: AgomAb Therapeutics NV
AGMBOct 9, 2026 · close 9.08
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | AgomAb Therapeutics NV | $94k 11,000 shares | +102% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | AGMB AgomAb Therapeutics NV | POpen-market purchase Common shares | +6,000 | $8.48 | $51k | 16,823 | 5 d ago |
| Oct 6, 2026 | AGMB AgomAb Therapeutics NV | POpen-market purchase Common shares | +5,000 | $8.70 | $44k | 21,823 | 5 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.